• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

医学文献>>
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
热搜词:
换一批

新生大鼠肠道组织中肠型脂肪酸结合蛋白的表达与坏死性小肠结肠炎的相关性

Relationship between intestinal fatty acid-binding protein expression and necrotizing enterocolitis in neonatal rat model

摘要目的 观察新生大鼠肠道组织中肠型脂肪酸结合蛋白(intestinal fatty acidbinding protein,I-FABP)的表达情况,探讨I-FABP与新生儿坏死性小肠结肠炎(necrotizing enterocolitis,NEC)的相关性. 方法 24只2日龄无特定病原体级新生Sprague-Dawley大鼠随机分为空白对照组(6只)和NEC模型组(18只).通过连续3d人工喂养+缺氧复氧+冷刺激+脂多糖灌胃(10 mg/kg)建立NEC模型,分别在造模成功后第1、2、3天随机选取6只大鼠空腹处死;空白对照组于NEC模型组造模成功后第3天空腹处死.处死后取大鼠回盲部肠管行组织病理评分,以及采用蛋白质印迹技术及免疫组织化学法检测回盲部肠组织I-FABP蛋白表达情况.采用单因素方差分析、LSD-t检验、Kruskal-Wallis H秩和检验、Mann-Whitney U检验,以及Pearson相关分析进行统计学分析. 结果NEC模型组大鼠全部顺利完成造模,造模过程中并无死亡,且肠组织病理学评分均≥2分,造模成功.NEC模型组造模后第1、2、3天体重增加[M(P25~P75)]均低于空白对照组[分别为1.00(0.48~1.35)与1.74(1.62~1.86)g,1.25(0.75~1.40)与2.61 (2.53~2.99)g,1.35 (0.88~1.48)与3.60(3.48~3.73)g,Z值分别为-2.898、-2.903及-2.892,P值均< 0.05],但肠组织病理学评分均高于空白对照组[分别为2(2~3)、3(2~3)、4(3~4)与0(0~1)分,P值均< 0.05],而NEC模型组造模后第3天大鼠肠组织病理评分显著高于造模后第1及第2天(P值均< 0.05).NEC模型组造模后第1、2、3天大鼠肠组织I-FABP表达水平及I-FABP阳性细胞数均高于空白对照组[I-FABP表达水平:0.179 (0.179~0.186)、0.231 (0.211~0.245)、0.202(0.192~0.225)与0.091(0.086~0.093);I-FABP阳性细胞数:59 (55~60)、80(83~86)、80(84~88)与44(39~47)个;P值均<0.05],与造模后第1天相比,NEC模型组造模后第2及3天大鼠肠组织I-FABP表达水平及I-FABP阳性细胞数均较高(P值均<0.05).蛋白质印迹技术与免疫组织化学法检测肠道组织I-FABP表达水平与肠道组织病理评分均呈正相关(r=0.932,95%CI:0.872~0.969;r=0.709,95%CI:0.484~0.872). 结论 I-FABP与NEC肠组织损伤程度存在相关性.

更多

abstractsObjective To analyze the role of intestinal fatty acid-binding protein (I-FABP) expression in a neonatal rat model of necrotizing enterocolitis (NEC).Methods A total of 24 newborn rats were randomly divided into two groups:control group (n=6) and NEC group (n=18).Rats in the NEC group were fed with formula and experienced hypoxia,reoxygenation,cold stress and sequentially Lipopolysaccharide (10 mg/kg) lavage for three consecutive days to establish NEC model,after which were respectively sacrificed on day 1,2 and 3 (six for each day).Those in the control group were all sacrificed on day 3.Ileocecal tissues were collected for morphological and histological analysis.I-FABP expression was detected using Western blot and immunohistochemistry (IHC).One-way analysis of variance,LSD-t test,Kruskal-Wallis H test,Mann-Whitney U test and Pearson's correlation analysis were used for statistical analysis.Results The NEC model (intestinal pathological score ≥ 2) was established successfully without causing death.Compared with the control group,the NEC group showed less body weight gain [M (P25-P75):1.00 (0.48-1.35) vs 1.74 (1.62-1.86),1.25 (0.75-1.40) vs 2.61 (2.53-2.99),1.35 (0.88-1.48) vs 3.60 (3.48-3.73);Z=-2.898,-2.903,-2.892;all P<0.05] and higher intestinal pathological scores [(2 (2-3),3 (2-3),4 (3-4) vs 0 (0-1);all P<0.05] on day 1,2 and 3.The intestinal pathological score on day 3 was significantly higher than that on day 2 and day 1 (both P<0.05).Expression of I-FABP and the number of I-FABP positive enterocytes in the NEC model group were increased compared with those in the control group [Western blot:0.179 (0.179-0.186),0.231 (0.211-0.245),0.202 (0.192-0.225) vs 0.091 (0.086-0.093);IHC:59 (55-60),80 (83-86),80 (84-88) vs 44 (39-47);all P<0.05].Moreover,the expression of I-FABP protein and the number of I-FABP positive enterocytes on day 2 and day 3 were significantly higher than those on day 1 (all P<0.05).I-FABP expression was positively associated with intestinal pathological score (Western blot:r=0.932,95%CI:0.872-0.969;IHC:r=0.709,95%CI:0.484-0.872).Conclusions I-FABP is an efficient marker for NEC and correlates with the severity of intestinal injury.

More
广告
栏目名称 临床科研
DOI 10.3760/cma.j.issn.1007-9408.2019.05.008
发布时间 2019-07-02
基金项目
福建省自然科学基金(2017J01162)Fujian Provincial Natural Science Foundation Project
  • 浏览259
  • 下载208
中华围产医学杂志

中华围产医学杂志

2019年22卷5期

336-340页

ISTICPKUCSCDCA

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

扩展文献

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷